Trial Profile
A phase I study of NK105 administrated weekly in patients with advanced solid malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Nippon Kayaku
- 05 Sep 2016 Results published in the Investigational New Drugs
- 02 Jun 2016 New trial record